These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5469691)

  • 21. Blood levels of rifampicin in liver diseases.
    Pozzi E; Menghini P
    Int J Clin Pharmacol; 1974 Jul; 10(1):44-9. PubMed ID: 4850803
    [No Abstract]   [Full Text] [Related]  

  • 22. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multicompartimental model for the study of drugs with high biliary excretion, used in the study of the kinetics of rifampicin in man].
    Acocella G; Pagani V; Nicolis FB
    Boll Chim Farm; 1972 Feb; 111(2):108-15. PubMed ID: 5045532
    [No Abstract]   [Full Text] [Related]  

  • 24. Urinary excretion of rifampicin and its metabolites as an index of rifampicin blood levels.
    Wardell WM; McQueen EG
    N Z Med J; 1970 Dec; 72(463):393-6. PubMed ID: 5278257
    [No Abstract]   [Full Text] [Related]  

  • 25. Sulfobromophtaalein sodium excretion and hepatic storage in Corriedale and Southdown sheep with inherited hepatic dysfunction.
    Gronwall R
    Am J Vet Res; 1970 Dec; 31(12):2131-3. PubMed ID: 5505142
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental study on rifamicin pharmacodynamics].
    Curci G; Ninni A; Di Mezza F
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):293-314. PubMed ID: 5307453
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biotransformation and its modification by barbiturates].
    Remmer H
    Z Gastroenterol; 1977 Jun; 15(6):362-72. PubMed ID: 888485
    [No Abstract]   [Full Text] [Related]  

  • 28. Physiological disposition of 2,6-dimethyl-4-benzyl-4-demethylrifampicin in rats, mice, and dogs.
    Wolpert MK; Lu K; Derr CJ; Loo TL; Johns DG
    Drug Metab Dispos; 1974; 2(3):237-46. PubMed ID: 4153001
    [No Abstract]   [Full Text] [Related]  

  • 29. Dynamic tests to study liver function.
    Burra P; Masier A
    Eur Rev Med Pharmacol Sci; 2004; 8(1):19-21. PubMed ID: 15209151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical studies with a new rifamycin derivative.
    Cohn HD
    J Clin Pharmacol J New Drugs; 1969; 9(2):118-25. PubMed ID: 4889468
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolism and pharmacokinetics of the antibiotic rifampin.
    Kenny MT; Strates B
    Drug Metab Rev; 1981; 12(1):159-218. PubMed ID: 7028436
    [No Abstract]   [Full Text] [Related]  

  • 32. Kinetic studies on the combination rifampicin-trimethoprim in man. I. Absorption and urinary excretion after administration to healthy volunteers of single doses of the two compounds alone and in combination, and of the combination over a period of 1 week.
    Acocella G; Scotti R
    J Antimicrob Chemother; 1976 Sep; 2(3):271-7. PubMed ID: 977527
    [No Abstract]   [Full Text] [Related]  

  • 33. Ringer's lactate infusion with severe hepatic damage: effect on arterial lactate level.
    Goldstein SM; MacLean LD
    Can J Surg; 1972 Sep; 15(5):318-21. PubMed ID: 5056995
    [No Abstract]   [Full Text] [Related]  

  • 34. [Metabolism of rifampicin. II. Distribution of rifampicin and its metabolites in normal rats and in rats with changes in the liver].
    Rodriguez Garay EA; Morisoli LS; Spetale MR; Rassero JA
    Farmaco Prat; 1973; 28(9):489-96. PubMed ID: 4751985
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
    Fromm MF; Busse D; Kroemer HK; Eichelbaum M
    Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intravenous loading with galactose as a liver function test. Methods and clinical value].
    Kuntz HD; Kuntz E
    Fortschr Med; 1983 Jun; 101(21):999-1004. PubMed ID: 6873856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and metabolic studies with labeled rifamycin antibiotics.
    Keberle H; Meyer-Brunot H; Schmid K
    Antimicrob Agents Chemother (Bethesda); 1966; 6():365-70. PubMed ID: 5985259
    [No Abstract]   [Full Text] [Related]  

  • 38. Clearance by the liver: current concepts in understanding the hepatic disposition of drugs.
    Larrey D; Branch RA
    Semin Liver Dis; 1983 Nov; 3(4):285-97. PubMed ID: 6359424
    [No Abstract]   [Full Text] [Related]  

  • 39. Distribution and excretion of rifamide in rats and dogs.
    Maffii G; Schiatti P
    Toxicol Appl Pharmacol; 1966 Jan; 8(1):138-51. PubMed ID: 5921889
    [No Abstract]   [Full Text] [Related]  

  • 40. Rifampin in the horse: comparison of intravenous, intramuscular, and oral administrations.
    Burrows GE; MacAllister CG; Beckstrom DA; Nick JT
    Am J Vet Res; 1985 Feb; 46(2):442-6. PubMed ID: 3994110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.